| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6001013 | Thrombosis Research | 2015 | 5 Pages |
Abstract
VTEs were observed less frequently in patients who were enrolled in HDCT than those who were enrolled in P1CT; however, patients with severe hepatic dysfunction were more likely to experience VTE. Severe liver test abnormalities may not be protective against VTE in patients with malignancies receiving chemotherapy.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
A.S. Mansfield, A.J. Tafur, D. Vulih, G.L. Smith, P.J. Harris, S.P. Ivy,